Session Details

F064 Platelet Rich Plasma

Sun, Mar 9, 1:00 PM - 3:00 PM
W307A
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will discuss various aspects of platelet rich plasma (PRP) including mechanism of action, preparation systems and dosing. This includes PRP protocols for various types of alopecia and skin rejuvenation. Platelet rich fibrin (PRF) will also be discussed along with stem cells and how they differ from PRP as well as combined uses for both skin and hair. Regulatory issues surrounding PRP, stem cells, and exosomes will also be discussed.

LEARNING OBJECTIVES

1.

Describe the mechanism of action of platelet rich plasma in the skin and hair.

2.

Discuss regulatory issues surrounding platelet rich plasma.

3.

Identify the various PRP preparation systems and how they compare to PRF/PRFM.

SCHEDULE

5:00 PM

Incorporating PRP into practice

Rohit Kakar, MD, FAAD

5:15 PM

PRP Preparation Systems

Terrence Keaney, MD, FAAD

5:30 PM

Platelet-based Therapies + Combination treatments

Robert L Finney, MD, FAAD

5:45 PM

Stem Cells & Exosomes

Ronda S. Farah, MD, FAAD

6:05 PM

Stem Cells & Exosomes

Rawn Edward Bosley, MD, FAAD

6:25 PM

Regenerative Medicine Legal Considerations

Ardalan Minokadeh, MD, PhD, FAAD

6:45 PM

Q&A

SPEAKERS

Rawn Edward Bosley, MD, FAAD

Rawn Edward Bosley, MD, FAAD

Ronda S. Farah, MD, FAAD

Ronda S. Farah, MD, FAAD

Robert L Finney, MD, FAAD

Robert L Finney, MD, FAAD

Rohit Kakar, MD, FAAD

Rohit Kakar, MD, FAAD

Terrence Keaney, MD, FAAD

Terrence Keaney, MD, FAAD

Ardalan Minokadeh, MD, PhD, FAAD

Ardalan Minokadeh, MD, PhD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Rawn Edward Bosley, MD, FAAD

Allergan Aesthetics – Advisory Board(Honoraria); Castle Biosciences, Inc – Advisory Board(Honoraria); Pfizer Inc. – Speaker(Honoraria); Revision Skincare – Consultant (1099 relationship)(Honoraria);

Ronda S. Farah, MD, FAAD

American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);

Robert L Finney, MD, FAAD

No financial relationships exist with ineligible companies.

Rohit Kakar, MD, FAAD

No financial relationships exist with ineligible companies.

Terrence Keaney, MD, FAAD

Allergan, Inc – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Crown Laboratories, Inc. – Advisory Board(Honoraria); DermTech Inc. – Investigator(Fees); Evolus, Inc. – Advisory Board(Honoraria); Galderma USA – Investigator(Fees); Kenvue – Advisory Board(Fees); Medytox Inc – Investigator(Fees); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Fees), Speaker(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Solta Medical – Advisory Board(Honoraria);

Ardalan Minokadeh, MD, PhD, FAAD

Allergan Aesthetics – Investigator(Grants/Research Funding); Evolus, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Galderma – Investigator(Grants/Research Funding); Merz Aesthetics – Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); symatese – Investigator(Grants/Research Funding);